LOS ANGELES, May 05, 2025 (GLOBE NEWSWIRE) -- PLBY Group, Inc. (NASDAQ: PLBY) (“PLBY Group” or the “Company”), a leading pleasure and leisure lifestyle company and owner of Playboy, one of the most recognizable and iconic brands in the world, will report first quarter 2025 financial results on Thursday, May 15, 2025, after the U.S. stock market closes. The Company will publish a press release discussing the quarter, including remarks from management, and then, at 5 p.m. Eastern Time, will host an analyst qu ...

The U.S. FDA has approved SELARSDI™ (ustekinumab-aekn) as interchangeable with the reference biologic Stelara® (ustekinumab) in all presentations matching the reference product, effective as of April 30, 2025SELARSDI is approved for all indications matching the reference productSELARSDI is indicated for the treatment of moderate to severe plaque psoriasis and active psoriatic arthritis in adults and pediatric patients 6 years and older, and the treatment of adult patients with moderately to severely active ...

TORONTO, May 05, 2025 (GLOBE NEWSWIRE) -- Xanadu Mines Ltd (ASX: XAM, TSX: XAM) (Xanadu or the Company) refers to its announcement dated 7 April 2025 in relation to the Extension of the Zijin Put Option and Exclusivity Arrangements1 with its major shareholder and Joint Venture Partner, Zijin Mining Group Co. Ltd (Zijin). Following substantive discussions with Zijin, the parties have been unable to finalise a control transaction within the agreed exclusivity period. Correspondingly, Xanadu’s exclusivity comm ...

Pershing Square to Support HHH’s Strategic Expansion Through Investment, Advisory, and Other Resources HHH Will Operate as a Diversified Holding Company Seeking to Acquire Controlling Interests in High-Quality, Durable Growth Public and Private Companies Howard Hughes Corporation, HHH’s Real Estate Development Business and Principal Subsidiary, Will Continue as the Nation’s Leading Community Builder Pershing Square’s Primary Purchase of HHH Stock for $100.00 per Share Represents a 48% Premium to Friday’s C ...

VANCOUVER, British Columbia, May 05, 2025 (GLOBE NEWSWIRE) -- Apollo Silver Corp. (“Apollo” or the “Company”) (TSX.V:APGO, OTCQB:APGOF, Frankfurt:6ZF0) is pleased to announce the appointment of Mr. Ross McElroy as President and CEO, effective immediately, succeeding Mr. Andrew Bowering, who will remain as Chair of the Board. Mr. McElroy joins Apollo following the successful acquisition of Fission Uranium, a company he co-founded and eventually led as CEO, by Paladin Energy in a $1.14 billion transaction. Mr ...

Core Insights - BioNTech reported a net loss of €415.8 million for Q1 2025, compared to a net loss of €315.1 million in Q1 2024, indicating a significant increase in losses year-over-year [3][7][10] - Revenues for Q1 2025 were €182.8 million, a decrease from €187.6 million in the same period last year, primarily driven by COVID-19 vaccine collaboration [3][10] - The company maintains a strong financial position with €15.9 billion in cash, cash equivalents, and security investments as of March 31, 2025 [8][9] Financial Review - Revenues for Q1 2025: €182.8 million, down from €187.6 million in Q1 2024 [3] - Net loss for Q1 2025: €415.8 million, compared to €315.1 million in Q1 2024 [7] - Basic and diluted loss per share: €1.73 for Q1 2025, up from €1.31 in Q1 2024 [9] - Cost of sales increased to €83.8 million in Q1 2025 from €59.1 million in Q1 2024 [4] - R&D expenses rose to €525.6 million in Q1 2025 from €507.5 million in Q1 2024, driven by late-stage clinical studies [5] - SG&A expenses decreased to €120.6 million in Q1 2025 from €132.6 million in Q1 2024 [6] Corporate Strategy and Outlook - BioNTech is focusing on advancing its oncology pipeline, particularly the bispecific antibody candidate BNT327 and mRNA cancer immunotherapies [8][17] - The company confirmed its financial guidance for 2025, expecting revenues between €1,700 million and €2,200 million, with a similar revenue phasing to 2024 [10][11] - Planned R&D expenses for 2025 are estimated between €2,600 million and €2,800 million, with SG&A expenses projected at €650 million to €750 million [11] Clinical Development Updates - BioNTech presented multiple clinical updates for its oncology pipeline, including promising data for BNT327 in combination with antibody-drug conjugates [8][19] - Preliminary data from ongoing trials indicate anti-tumor activity and manageable safety profiles for BNT327 in various cancer indications [18][19] - The company is preparing for the 2025/2026 season variant-adapted COVID-19 vaccine [8][26] Management Changes - Ramón Zapata-Gomez has been appointed as the new CFO effective July 1, 2025, succeeding Jens Holstein [26]

Company Overview - Descartes Systems Group is a global leader in providing on-demand, software-as-a-service solutions aimed at enhancing the productivity, security, and sustainability of logistics-intensive businesses [4] - The company offers modular solutions for various logistics processes, including routing, tracking, shipment planning, transportation invoice management, and customs documentation [4] Upcoming Financial Results - Descartes is scheduled to report its first quarter fiscal 2026 financial results after market close on June 4, 2025 [1] - An executive management team conference call will be held at 5:30 p.m. ET on the same day to discuss the financial results [2] Conference Call Details - The conference call can be accessed via designated numbers for North America and international participants, with a conference ID of 26605 [2] - A replay of the conference call will be available until June 11, 2025, along with an archived webcast on the company's investor relations website [3]

Core Viewpoint - Dundee Precious Metals Inc. announces the passing of R. Peter Gillin, the Chair of the Board since 2022, who significantly contributed to the company's transformation into a responsible precious metals producer [1][2][3] Leadership Transition - Following the passing of R. Peter Gillin, Juanita Montalvo has been appointed as the new Chair of the Board, bringing over 25 years of international experience in the mining sector and a strong governance background [4] Company Overview - Dundee Precious Metals Inc. is a Canadian-based international gold mining company with operations in Bulgaria, Serbia, and Ecuador, aiming to become a mid-tier precious metals company focused on sustainable and efficient gold production [5]

Group 1 - Kalmar Corporation is involved in critical supply chains globally, focusing on sustainable material handling equipment and services [2] - The company operates in over 120 countries and employs approximately 5,200 people [2] - In 2024, Kalmar's sales totaled approximately EUR 1.7 billion [2] Group 2 - A member of the Board, Casimir Lindholm, received a share-based incentive on April 30, 2025, involving 1,512 shares at a unit price of 0.00 EUR [1] - The transaction was reported as an initial notification under the relevant regulations [1]

Group 1 - Kalmar Corporation is focused on sustainable material handling equipment and services, aiming to be a leader in the industry [2] - The company operates globally in over 120 countries and employs approximately 5,200 people [2] - In 2024, Kalmar's sales totaled approximately EUR 1.7 billion [2] Group 2 - A member of the board, Vesa Laisi, received a share-based incentive of 1,512 shares on April 30, 2025, with a unit price of 0.00 EUR [1] - The transaction was reported as an initial notification and took place on the XHEL venue [1] - The aggregated volume weighted average price for the transaction was also 0.00 EUR [1]